US Stock MarketDetailed Quotes

INFI Infinity Pharmaceuticals

Watchlist
  • 0.008
  • 0.0000.00%
15min DelayClose Oct 3 16:00 ET
726.09KMarket Cap-17P/E (TTM)

Infinity Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
24.43%-8.01M
7.09%-12.58M
-4.46%-42.43M
8.42%-8.9M
-19.58%-9.4M
-10.73%-10.6M
-0.48%-13.54M
-13.65%-40.62M
-14.20%-9.72M
0.27%-7.86M
Net income from continuing operations
16.94%-9.96M
11.19%-11.05M
1.97%-44.37M
20.78%-9.23M
-0.04%-10.72M
-6.36%-11.99M
-6.94%-12.44M
-11.78%-45.26M
-9.93%-11.65M
-12.37%-10.71M
Depreciation and amortization
-11.67%106K
-13.22%105K
-4.58%458K
-11.67%106K
-8.26%111K
0.00%120K
1.68%121K
-0.62%480K
0.84%120K
-0.82%121K
Other non cash items
1.13%-263K
-96.50%-562K
-47.92%-1.1M
-192.77%-243K
-18.99%-307K
-18.22%-266K
-59.78%-286K
-152.13%-745K
-150.92%-83K
-153.53%-258K
Change In working capital
73.13%1.25M
-58.13%-2.85M
-146.93%-1.04M
-147.27%-555K
-73.16%595K
-36.33%722K
22.07%-1.8M
59.86%2.21M
-17.03%1.17M
215.36%2.22M
-Change in prepaid assets
1,059.26%518K
62.99%-581K
-443.27%-587K
34.67%369K
51.82%668K
-159.34%-54K
-147.63%-1.57M
-70.77%171K
-2.84%274K
1,529.63%440K
-Change in payables and accrued expense
-4.93%772K
-1,036.22%-2.23M
-113.78%-300K
-189.37%-883K
-101.88%-33K
-24.47%812K
88.09%-196K
146.83%2.18M
-18.62%988K
206.62%1.76M
-Change in other current assets
15.56%104K
14.94%100K
3.38%367K
29.73%96K
-11.32%94K
-2.17%90K
4.82%87K
19.13%355K
10.45%74K
9.28%106K
-Change in other current liabilities
-14.29%-144K
-14.75%-140K
-6.13%-519K
15.43%-137K
-50.56%-134K
-1.61%-126K
-7.02%-122K
-28.68%-489K
-9.46%-162K
-1,880.00%-89K
Cash from discontinued investing activities
Operating cash flow
24.43%-8.01M
7.09%-12.58M
-4.46%-42.43M
8.42%-8.9M
-19.58%-9.4M
-10.73%-10.6M
-0.48%-13.54M
-13.65%-40.62M
-14.20%-9.72M
0.27%-7.86M
Investing cash flow
Cash flow from continuing investing activities
0
0
-101.00%-55K
0
97,654.55%10.73M
3.28M
-355.75%-14.07M
-62.48%5.49M
0
99.88%-11K
Net PPE purchase and sale
--0
--0
-54.55%-17K
--0
--0
--0
---17K
74.42%-11K
--0
---11K
Net investment purchase and sale
--0
--0
-100.69%-38K
--0
--10.73M
--3.28M
-355.44%-14.05M
-62.52%5.5M
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
-101.00%-55K
--0
97,654.55%10.73M
--3.28M
-355.75%-14.07M
-62.48%5.49M
--0
99.88%-11K
Financing cash flow
Cash flow from continuing financing activities
-99.92%73K
-91.29%31K
-97.44%14K
217.43%87.11M
-73.75%356K
-91.58%546K
Net common stock issuance
----
----
-99.92%73K
-91.29%31K
-97.44%14K
----
----
1,006.94%87.11M
-73.75%356K
-91.58%546K
Cash from discontinued financing activities
Financing cash flow
----
----
-99.92%73K
-91.29%31K
-97.44%14K
----
----
217.43%87.11M
-73.75%356K
-91.58%546K
Net cash flow
Beginning cash position
-51.40%25.9M
-52.44%38.47M
179.80%80.88M
-47.54%47.34M
-52.86%46M
-50.24%53.28M
179.80%80.88M
28.05%28.91M
378.94%90.25M
233.74%97.57M
Current changes in cash
-9.66%-7.99M
54.44%-12.58M
-181.60%-42.41M
5.27%-8.87M
118.34%1.34M
23.28%-7.29M
-135.31%-27.6M
720.72%51.98M
-193.02%-9.36M
29.50%-7.33M
End cash Position
-61.07%17.9M
-51.40%25.9M
-52.44%38.47M
-52.44%38.47M
-47.54%47.34M
-52.86%46M
-50.24%53.28M
179.80%80.88M
179.80%80.88M
378.94%90.25M
Free cash flow
24.43%-8.01M
7.20%-12.58M
-4.48%-42.45M
8.42%-8.9M
-19.41%-9.4M
-10.73%-10.6M
-0.61%-13.55M
-13.55%-40.63M
-14.21%-9.72M
0.13%-7.87M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 24.43%-8.01M7.09%-12.58M-4.46%-42.43M8.42%-8.9M-19.58%-9.4M-10.73%-10.6M-0.48%-13.54M-13.65%-40.62M-14.20%-9.72M0.27%-7.86M
Net income from continuing operations 16.94%-9.96M11.19%-11.05M1.97%-44.37M20.78%-9.23M-0.04%-10.72M-6.36%-11.99M-6.94%-12.44M-11.78%-45.26M-9.93%-11.65M-12.37%-10.71M
Depreciation and amortization -11.67%106K-13.22%105K-4.58%458K-11.67%106K-8.26%111K0.00%120K1.68%121K-0.62%480K0.84%120K-0.82%121K
Other non cash items 1.13%-263K-96.50%-562K-47.92%-1.1M-192.77%-243K-18.99%-307K-18.22%-266K-59.78%-286K-152.13%-745K-150.92%-83K-153.53%-258K
Change In working capital 73.13%1.25M-58.13%-2.85M-146.93%-1.04M-147.27%-555K-73.16%595K-36.33%722K22.07%-1.8M59.86%2.21M-17.03%1.17M215.36%2.22M
-Change in prepaid assets 1,059.26%518K62.99%-581K-443.27%-587K34.67%369K51.82%668K-159.34%-54K-147.63%-1.57M-70.77%171K-2.84%274K1,529.63%440K
-Change in payables and accrued expense -4.93%772K-1,036.22%-2.23M-113.78%-300K-189.37%-883K-101.88%-33K-24.47%812K88.09%-196K146.83%2.18M-18.62%988K206.62%1.76M
-Change in other current assets 15.56%104K14.94%100K3.38%367K29.73%96K-11.32%94K-2.17%90K4.82%87K19.13%355K10.45%74K9.28%106K
-Change in other current liabilities -14.29%-144K-14.75%-140K-6.13%-519K15.43%-137K-50.56%-134K-1.61%-126K-7.02%-122K-28.68%-489K-9.46%-162K-1,880.00%-89K
Cash from discontinued investing activities
Operating cash flow 24.43%-8.01M7.09%-12.58M-4.46%-42.43M8.42%-8.9M-19.58%-9.4M-10.73%-10.6M-0.48%-13.54M-13.65%-40.62M-14.20%-9.72M0.27%-7.86M
Investing cash flow
Cash flow from continuing investing activities 00-101.00%-55K097,654.55%10.73M3.28M-355.75%-14.07M-62.48%5.49M099.88%-11K
Net PPE purchase and sale --0--0-54.55%-17K--0--0--0---17K74.42%-11K--0---11K
Net investment purchase and sale --0--0-100.69%-38K--0--10.73M--3.28M-355.44%-14.05M-62.52%5.5M--0--0
Cash from discontinued investing activities
Investing cash flow --0--0-101.00%-55K--097,654.55%10.73M--3.28M-355.75%-14.07M-62.48%5.49M--099.88%-11K
Financing cash flow
Cash flow from continuing financing activities -99.92%73K-91.29%31K-97.44%14K217.43%87.11M-73.75%356K-91.58%546K
Net common stock issuance ---------99.92%73K-91.29%31K-97.44%14K--------1,006.94%87.11M-73.75%356K-91.58%546K
Cash from discontinued financing activities
Financing cash flow ---------99.92%73K-91.29%31K-97.44%14K--------217.43%87.11M-73.75%356K-91.58%546K
Net cash flow
Beginning cash position -51.40%25.9M-52.44%38.47M179.80%80.88M-47.54%47.34M-52.86%46M-50.24%53.28M179.80%80.88M28.05%28.91M378.94%90.25M233.74%97.57M
Current changes in cash -9.66%-7.99M54.44%-12.58M-181.60%-42.41M5.27%-8.87M118.34%1.34M23.28%-7.29M-135.31%-27.6M720.72%51.98M-193.02%-9.36M29.50%-7.33M
End cash Position -61.07%17.9M-51.40%25.9M-52.44%38.47M-52.44%38.47M-47.54%47.34M-52.86%46M-50.24%53.28M179.80%80.88M179.80%80.88M378.94%90.25M
Free cash flow 24.43%-8.01M7.20%-12.58M-4.48%-42.45M8.42%-8.9M-19.41%-9.4M-10.73%-10.6M-0.61%-13.55M-13.55%-40.63M-14.21%-9.72M0.13%-7.87M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data